• Neurodegeneration and inflammation—an interesting interplay in parkinson’s disease 

      Marogianni C., Sokratous M., Dardiotis E., Hadjigeorgiou G.M., Bogdanos D., Xiromerisiou G. (2020)
      Parkinson’s disease (PD) is a neurodegenerative disorder, caused by, so far, unknown pathogenetic mechanisms. There is no doubt that pro-inflammatory immune-mediated mechanisms are pivotal to the pathogenicity and progression ...
    • Parkinson's disease and pesticides: Are microRNAs the missing link? 

      Aloizou A.-M., Siokas V., Sapouni E.-M., Sita N., Liampas I., Brotis A.G., Rakitskii V.N., Burykina T.I., Aschner M., Bogdanos D.P., Tsatsakis A., Hadjigeorgiou G.M., Dardiotis E. (2020)
      Parkinson's disease (PD) is a common neurodegenerative disorder that leads to significant morbidity and decline in the quality of life. It develops due to loss of dopaminergic neurons in the substantia nigra pars compacta, ...
    • PKC and Ras differentially regulate gene expression of the dopaminergic marker TH and noradrenergic marker DBH 

      Theofilopoulos, S.; Tsirimonaki, E.; Sakellaridis, N.; Mangoura, D. (2007)
      We have successfully established for the first time in the literature cell lines from human fetal cells derived from the amniotic fluid (AF) and have documented that these cells may progress and stably express many of the ...